Examining the Bactericidal Behavior of a New MRSA Treatment
March 17th 2017Daniel Pilch, PhD, associate professor in the Department of Pharmacology at Rutgers Robert Wood Johnson Medical School, co-founder of TAXIS Pharmaceuticals, and co-author of the study, explains the bactericidal behavior of TXA709, a new drug to treat MRSA infections.
Read More
Edmond LaVoie, PhD, professor and chair, Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers University, co-founder of TAXIS Pharmaceuticals, and co-author of the study on the new MRSA drug, TXA709, explains how TXA709 targets MRSA differently than other antibiotics.
Read More
How Effective is TXA709 Against MRSA?
February 16th 2017Daniel Pilch, PhD, associate professor in the Department of Pharmacology at Rutgers Robert Wood Johnson Medical School, co-founder of TAXIS Pharmaceuticals, and co-author of the study, explains why MRSA is especially dangerous, and the effectiveness of the team’s new drug, TXA079.
Read More
Assessing the Clinical Wellbeing of SSTI Patients
February 10th 2017Michael D. Nailor, PharmD, BCPS-AQ ID, clinical associate professor at the University of Connecticut School of Pharmacy, clinical specialist in infectious diseases at Hartford Hospital, and director of Infectious Disease Residency program at Hartford Hospital, explains how his research can assess clinical well-being of patients with skin and soft tissue infections.
Read More
Reducing Readmission Rates Among SSTI Patients
February 4th 2017Michael D. Nailor, PharmD, BCPS-AQ ID, clinical associate professor at the University of Connecticut School of Pharmacy, clinical specialist in infectious diseases at Hartford Hospital, and director of Infectious Disease Residency program at Hartford Hospital, discusses the clinical significance of the results of his study on readmission rates among patients with skin and soft tissue infections.
Read More
High Readmission Rates Among Patients with Skin and Soft Tissue Infections
February 1st 2017Michael D. Nailor, PharmD, BCPS-AQ ID, clinical associate professor at the University of Connecticut School of Pharmacy, clinical specialist in infectious diseases at Hartford Hospital, and director of Infectious Disease Residency program at Hartford Hospital, explains that resources for skin and soft tissue infections need to be directed at emergency departments.
Read More
Understanding the Prevalence of Skin and Soft Tissue Infections
January 23rd 2017Michael D. Nailor, PharmD, BCPS-AQ ID, clinical associate professor at the University of Connecticut School of Pharmacy, clinical specialist in infectious diseases at Hartford Hospital, and director of Infectious Disease Residency program at Hartford Hospital, explains why it’s important to understand the prevalence of skin and soft tissue infections.
Read More
Challenges With Classifying and Treating Skin and Soft Tissue Infections
January 16th 2017Michael D. Nailor, PharmD, BCPS-AQ ID, clinical associate professor at the University of Connecticut School of Pharmacy, clinical specialist in infectious diseases at Hartford Hospital, and director of Infectious Disease Residency program at Hartford Hospital, discusses the biggest challenges associated with classifying and treating skin and soft tissue infections.
Read More
Exploring Drug Resistance Among Pathogens That Cause Skin and Soft Tissue Infections
January 11th 2017Michael D. Nailor, PharmD, BCPS-AQ ID, clinical associate professor at the University of Connecticut School of Pharmacy, clinical specialist in infectious diseases at Hartford Hospital, and director of Infectious Disease Residency program at Hartford Hospital, discusses which skin and soft tissue infections (SSTIs) are likely to be drug-resistant.
Read More
Surge in Mumps Outbreaks Seen Across the US
December 14th 2016The United States is experiencing its biggest mumps outbreak in years, causing a surge of cases across the country after several years of relatively few cases. This has prompted health officials to take steps to prevent further spread of the disease.
Read More
New Genetic Research Shows How Epstein-Barr Virus Leads to Cancer
November 17th 2016Researchers in the United Kingdom have made a new genetic discovery in the link between Epstein-Barr virus and related cancers, including a potential way to stop the cancer-causing effects of these infections.
Read More
Measles Control & Eradication Efforts Fall Short of 2015 WHA Goals
November 15th 2016A recent analysis by the Centers for Disease Control and Prevention found that strides have been made in the fight against measles; however, the work still falls short of goals set by the World Health Assembly (WHA).
Read More